Newsletters
The Capitalist Newsletter – June 16, 2017
GUY COHEN GIVES A QUICK RUNDOWN OF LAST FRIDAY’S FREEFALL |
|
Winners & Losers – Adamis Pharmaceuticals, Inc. (ADMP) Rockets UP (53.33%) After Rival Epipen Product Gets FDA Approval – The Kroger Co. (KR) Sinks DOWN (18.89%) After Company Issues Warning that Profit Could Shrink
Most Talked About Snap, Inc. (SNAP) Considered a Majority Strong Sell After Shares Sink Back to Pre-IPO Launch Price
The TIP Sheets – Thursday, June 15th – Adamis Pharmaceuticals, Inc. (ADMP) Rockets UP (53.33%) After its Rival Epipen Product Gets FDA Approval. With Epipen Being the Poster Boy for Big Pharma Evil, Expect Shares to Continue UP
Unusual Volume
The Kroger Co. (KR) Sinks DOWN (18.89%) on 76m Shares Traded After Company Issues Warning that Profits Could Shrink. As Amazon and Other Online Retailers Get into Grocery Game, Expect Shares to Continue DOWN |